Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Diabetic Peripheral Neuropathic Pain

In brief

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic peripheral neuropathy (DPN).

Key facts

Study ID
NCT07231419
Run by
Vertex Pharmaceuticals Incorporated
People needed
734
Starts
2025-11-21
Expected to finish
2027-04-06
Last updated by the study team
2026-07-20

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.